Protect Yourself from Dangerous Carbamazepine Reactions
If you’re about to start Carbamazepine treatment for epilepsy, nerve pain, or bipolar disorder, this genetic test could save you from severe, potentially life-threatening skin reactions. The HLA-B1502 Genotyping test identifies your genetic risk before you take your first dose, giving you and your doctor the confidence to proceed safely with treatment.
What This Test Reveals About Your Medication Safety
The HLA-B1502 Genotyping test examines your specific genetic makeup to determine if you carry the HLA-B*1502 gene variant. When people with this gene take Carbamazepine, they can develop severe skin reactions including Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis – conditions that can be fatal without immediate medical care.
Our advanced Sanger Sequencing technology provides 99.9% accuracy, ensuring you receive reliable, trustworthy results that your healthcare provider can use to make informed treatment decisions.
Who Should Take This Essential Safety Test?
- Patients prescribed Carbamazepine for the first time for epilepsy, trigeminal neuralgia, or bipolar disorder
- Individuals of Asian descent (higher risk population for HLA-B*1502 variant)
- Patients with family history of medication allergies or severe skin reactions
- Anyone concerned about medication safety before starting new treatment
- Patients switching from other medications to Carbamazepine therapy
If you’re feeling anxious about starting new medication or have experienced medication reactions in the past, this test provides the reassurance you need.
Why This Test Matters for Your Health Journey
- Prevent serious complications before they occur
- Gain peace of mind knowing your treatment is safe for you
- Empower your doctor with genetic information for personalized care
- Avoid hospitalisation and extended medical costs
- Take control of your treatment safety and outcomes
Understanding Your Results – Clear Guidance for Peace of Mind
Your results will clearly indicate whether you carry the HLA-B*1502 gene variant:
- Negative Result: You can proceed with Carbamazepine treatment with significantly reduced risk of severe skin reactions
- Positive Result: Your doctor will recommend alternative medications that are safe for your genetic profile
Our medical team provides comprehensive result interpretation, and we recommend sharing your results directly with your prescribing physician for the best treatment planning.
Affordable Protection for Your Health
| Test | Regular Price | Special Price | Turnaround |
|---|---|---|---|
| HLA-B1502 Genotyping | ZAR 2,350 | ZAR 1,750 | 10 Days |
Consider this: The cost of treating severe medication reactions can exceed ZAR 50,000 in hospital bills. This ZAR 1,750 test could save you from significant medical expenses and protect your health.
Why South Africans Trust Oracle Genomics
- Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Medical Expertise: Specialised genetic testing with gynecologist oversight
- Accuracy Guarantee: 99.9% reliable results using Sanger Sequencing
- Quick Results: Comprehensive report within 10 days
- Professional Support: Clear guidance and result interpretation
Take Control of Your Medication Safety Today
Don’t wait until it’s too late. This simple blood test requires just a 2ml sample and could prevent serious health complications. With our special pricing of ZAR 1,750, protecting yourself has never been more affordable.
Important Note: This test requires a doctor’s prescription for medication safety purposes. Prescription is not required for surgery preparation, pregnancy planning, or international travel documentation.
Call us today: Speak with our genetic counsellors to understand how this test fits your health needs
Available nationwide: Johannesburg • Cape Town • Durban • Pretoria • Port Elizabeth • Bloemfontein • and all major South African cities
